The cost-effectiveness of biologic versus non-biologic treatments and the health-related quality of life among a sample of patients with inflammatory bowel disease in a tertiary care center in Saudi Arabia.
Yazed Sulaiman H Al-RuthiaMajid Abdularahman AlmadiAbdulrahman M AljebreenNahla Ali AzzamWejdan AlsharifHala AlrasheedGhadah AlmuaythirMaria SaeedBaraa HajkhderMullaissaOthman AlharbiPublished in: Journal of medical economics (2020)
The results of this analysis can serve as a foundation to introduce HRQoL-based recommendations for the use of biologics in the management of IBD in Saudi Arabia.